- Location
Ikaria
"-
Ikaria Would Sell The Commercial Business to Madison Dearborn Partners
Dec 30, 2013Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders ...
Tags: Ikaria, sell the Commercial Business, Madison Dearborn Partners
-
Madison Dearborn Partners Will Receive a Minority Stake in The Acquiror Company
Dec 27, 2013Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care ...
-
Ceretec Launches a NO Lung Diffusion Gas Mixture, NO-Diff, for DLNO Testing
Dec 17, 2012Ceretec has launched a nitric-oxide (NO) lung diffusion gas mixture, NO-Diff, for use in membrane diffusing capacity (DLNO) testing in pulmonary function laboratories in the US. The gas product, classified as Class 1 medical device by ...
Tags: medical device, lung diffusion gas mixture, clinical technology
-
TGA of Australia Has Approved Ikaria Lucassin
Apr 25, 2012The Therapeutic Goods Administration (TGA) of Australia has approved Ikaria Lucassin (terlipressin) for the treatment of Hepatorenal Syndrome Type 1 (HRS 1) in patients who are actively being considered for a liver transplant. The ...
